Interval cancers after negative immunochemical test compared to screen and non-responders’ detected cancers in Slovenian colorectal cancer screening programme
References
- Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-86. 10.1002/ijc.29210
- Zadnik V, Primic Zakelj M, Lokar K, Jarm K, Ivanus U, Zagar T. Cancer burden in Slovenia with the time trends analysis. Radiol Oncol 2017; 51: 47-55. 10.1515/raon-2017-0008
- Proposal for a Council Recommendation on Cancer Screening. Commission of the European Communities. 2003/0093(CNS). [cited 2018 Mar 15]. Available from: http://ec.europa.eu/health/ph_determinants/genetics/documents/com_2003_0230_en.pdf
- Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365-71. 10.1056/NEJM199305133281901
- Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-71. 10.1016/S0140-6736(96)03430-7
- Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-7. 10.1016/S0140-6736(96)03386-7
- Segnan N, Patnick J, von Karsa L, editors. European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis. First edition. European Commission. Luxembourg: Publications Office of the European Union; 2010 [cited 2018 Mar 15]. Available from: http://www.stopdarmkanker.be/BOEKJE/boekEU.pdf
- Duffy MJ, van Rossum LG, van Turenhout ST, Malminiemi O, Sturgeon C, Lamerz R, et al. Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper. Int J Cancer 2011; 128: 3-11. 10.1002/ijc.25654
- Raffle A, Gray M. Screening: Evidence and Practice. Oxford: University Press; 2007.
- Sanduleanu S, le Clercq CM, Dekker E, Meijer GA, Rabeneck L, Rutter MD, et al. Definition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclature. Gut 2015; 64: 1257-67. 10.1136/gutjnl-2014-307992
- Steele RJ, McClements P, Watling C, Libby G, Weller D, Brewster DH, et al. Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site. Gut 2012; 6: 576-81. 10.1136/gutjnl-2011-300535
- Grazzini G, Visioli CB, Zorzi M, Ciatto S, Banovich F, Bonanomi AG, et al. Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? Br J Cancer 2009; 100: 259-65. 10.1038/sj.bjc.6604864
- Zorzi M, Fedato C, Grazzini G, Stocco FC, Banovich F, Bortoli A, et al. High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy. Gut 2011; 60: 944-9. 10.1136/gut.2010.223982
- Tepeš B, Stefanovič M, Bračko M, Frković Grazio S, Maučec Zakotnik J, Novak Mlakar D, et al. [Slovenian colorectal cancer screening programme SVIT - results of pilot phase.] [Slovenian]. Zdrav Vestn 2010; 79: 403-11.
- Tepeš B, Bracko M, Novak Mlakar D, Stefanovic M, Stabuc B, Frkovic Grazio S, et al. Results of the FIT-based National Colorectal Cancer Screening Program in Slovenia. J Clin Gastroenterol 2017; 51: e52-9. 10.1097/MCG.0000000000000662
- Tepeš B, Kasesnik K, Novak Mlakar D, editos. [Slovenian guidelines of colorectal cancer screening programme SVIT: Slovenian guidelines ensure the quality of colorectal cancer screening.] [Slovenian]. First edition. Ljubljana: Nacionalni inštitut za javno zdravje; 2016.
- International Classification of Diseases for Oncology, 3rd Edition. Geneva, Switzerland: World Health Organization; 2000.
- Hakama M, Auvinen A, Day NE, Miller AB. Sensitivity in cancer screening. J Med Screen 2007; 14: 174-7. 10.1258/096914107782912077
- Malila N, Oivanen T, Malminiemi O, Hakama M. Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design. BMJ 2008; 337: a2261. 10.1136/bmj.a2261
- GISCoR Working Group, Zorzi M (Coordinator). Detection of the interval cancers and estimate of the sensitivity of colorectal cancer screening programmes. Working report. Epidemiol Prev 2013; 37 (2-3 Suppl 1) [cited 2018 Mar 15]. Available from: http://www.epiprev.it/materiali/2013/EP2-3/S1_GISCOR/GISCOR_2013_Eng_def.pdf
- Zappa M, Castiglione G, Paci E, Grazzini G, Rubeca T, Turco P, et al. Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: the District of Florence experience. Int J Cancer 2001; 92: 151-4. 10.1002/1097-0215(200102)9999:9999<;::AID-IJC1149>3.0.CO;2-6
- van der Vlugt M, Grobbee EJ, Bossuyt PMM, Bos A, Bongers E, Spijker W, et al. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing. Gastroenterology 2017; 153: 439-47. 10.1053/j.gastro.2017.05.004
- Portillo I, Arana-Arri E, Idigoras I, Bilbao I, Martínez-Indart L, World LB, et al. Colorectal and interval cancers of the Colorectal Cancer Screening Program in the Basque Country (Spain). J Gastroenterol 2017; 23: 2731-42. 10.3748/wjg.v23.i15.2731
- Senore C, Armaroli P, Silvani M, Andreoni B, Bisanti L, Marai L, et al. Comparing different strategies for colorectal cancer screening in Italy: predictors of patients’ participation. Am J Gastroenterol 2010; 105: 188-98. 10.1038/ajg.2009.583
- Garcia M, Domènech X, Vidal C, Torné E, Milà N, Binefa G, et al. Interval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain. Gastroenterol Res Pract 2015; 2015: 672410. Published online 2015 Feb 24. 10.1155/2015/672410
- Steele RJ, Stanners G, Lang J, Brewster DH, Carey FA, Fraser CG. Interval cancers in a national colorectal cancer screening programme. United European Gastroenterol J 2016; 4: 587-94. 10.1177/2050640615624294
- Morris EJA, Whitehouse LE, Farrell T, Nickerson C, Thomas JD, Quirke P, et al. A retrospective observational study examining the characteristics and outcomes of tumours diagnosed within and without of the English NHS Bowel Cancer Screening Programme. Br J Cancer 2012; 107: 757-64. 10.1038/bjc.2012.331
- Gill MD, Bramble MG, Rees CJ, Lee TJ, Bradburn DM, Mills SJ. Comparison of screen-detected and interval colorectal cancers in the Bowel Cancer Screening Programme. Br J Cancer 2012; 107: 417-21. 10.1038/bjc.2012.305
- Paimela H, Malila N, Palva T, Hakulinen T, Vertio H, Järvinen H. Early detection of colorectal cancer with faecal occult blood test screening. Br J Surg 2010; 97: 1567-71. 10.1002/bjs.7150
- Barnett KN, Weller D, Smith S, Steele RJ, Vedsted P, Orbell S, et al. The contribution of a negative colorectal screening test result to symptom appraisal and help-seeking behaviour among patients subsequently diagnosed with an interval colorectal cancer. Health Expect 2018. 10.1111/hex.12672
- Digby J, Fraser CG, Carey FA, Lang J, Stanners G, Steele RJ. Interval cancers using a quantitative faecal immunochemical test (FIT) for haemoglobin when colonoscopy capacity is limited. J Med Screen 2016; 23: 130-4. 10.1177/0969141315609634
Language: English
Page range: 413 - 421
Submitted on: Apr 17, 2018
Accepted on: May 20, 2018
Published on: Jul 12, 2018
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2018 Dominika Novak Mlakar, Tatjana Kofol Bric, Ana Lucija Škrjanec, Mateja Krajc, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.